Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Gastroesophageal Reflux Disease (GERD) Drugs and Devices market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Gastroesophageal Reflux Disease (GERD) Drugs and Devices market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices market size and forecasts, in consumption value ($ Million), 2018-2029
Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Gastroesophageal Reflux Disease (GERD) Drugs and Devices
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Gastroesophageal Reflux Disease (GERD) Drugs and Devices market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca, Plc., Addex Therapeutics, Takeda Pharmaceutical Company Limited, Rottapharm (Meda AB) and Pfizer, Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Gastroesophageal Reflux Disease (GERD) Drugs and Devices market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Gastroesophageal Reflux Disease (GERD) Drugs and Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Gastroesophageal Reflux Disease (GERD) Drugs and Devices, with revenue, gross margin and global market share of Gastroesophageal Reflux Disease (GERD) Drugs and Devices from 2018 to 2023.
Chapter 3, the Gastroesophageal Reflux Disease (GERD) Drugs and Devices competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Gastroesophageal Reflux Disease (GERD) Drugs and Devices market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Gastroesophageal Reflux Disease (GERD) Drugs and Devices.
Chapter 13, to describe Gastroesophageal Reflux Disease (GERD) Drugs and Devices research findings and conclusion.
This report is a detailed and comprehensive analysis for global Gastroesophageal Reflux Disease (GERD) Drugs and Devices market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices market size and forecasts, in consumption value ($ Million), 2018-2029
Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Gastroesophageal Reflux Disease (GERD) Drugs and Devices
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Gastroesophageal Reflux Disease (GERD) Drugs and Devices market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca, Plc., Addex Therapeutics, Takeda Pharmaceutical Company Limited, Rottapharm (Meda AB) and Pfizer, Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Gastroesophageal Reflux Disease (GERD) Drugs and Devices market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Medication
- Minimally Invasive Surgery
- Invasive Surgery
- Heartburn
- Acid reflux disorders
- AstraZeneca, Plc.
- Addex Therapeutics
- Takeda Pharmaceutical Company Limited
- Rottapharm (Meda AB)
- Pfizer, Inc.
- Eisai Co. Ltd.
- The Procter & Gamble Company
- Mederi Therapeutics
- Aros Pharma
- Torax Medical, Inc.
- BD
- EndoGastric Solutions
- Medigus Ltd.
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Gastroesophageal Reflux Disease (GERD) Drugs and Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Gastroesophageal Reflux Disease (GERD) Drugs and Devices, with revenue, gross margin and global market share of Gastroesophageal Reflux Disease (GERD) Drugs and Devices from 2018 to 2023.
Chapter 3, the Gastroesophageal Reflux Disease (GERD) Drugs and Devices competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Gastroesophageal Reflux Disease (GERD) Drugs and Devices market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Gastroesophageal Reflux Disease (GERD) Drugs and Devices.
Chapter 13, to describe Gastroesophageal Reflux Disease (GERD) Drugs and Devices research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Gastroesophageal Reflux Disease (GERD) Drugs and Devices
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Gastroesophageal Reflux Disease (GERD) Drugs and Devices by Type
1.3.1 Overview: Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Market Share by Type in 2022
1.3.3 Medication
1.3.4 Minimally Invasive Surgery
1.3.5 Invasive Surgery
1.4 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market by Application
1.4.1 Overview: Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Heartburn
1.4.3 Acid reflux disorders
1.5 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size & Forecast
1.6 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast by Region
1.6.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Region, (2018-2029)
1.6.3 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Prospect (2018-2029)
1.6.4 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Prospect (2018-2029)
1.6.6 South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 AstraZeneca, Plc.
2.1.1 AstraZeneca, Plc. Details
2.1.2 AstraZeneca, Plc. Major Business
2.1.3 AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
2.1.4 AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 AstraZeneca, Plc. Recent Developments and Future Plans
2.2 Addex Therapeutics
2.2.1 Addex Therapeutics Details
2.2.2 Addex Therapeutics Major Business
2.2.3 Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
2.2.4 Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Addex Therapeutics Recent Developments and Future Plans
2.3 Takeda Pharmaceutical Company Limited
2.3.1 Takeda Pharmaceutical Company Limited Details
2.3.2 Takeda Pharmaceutical Company Limited Major Business
2.3.3 Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
2.3.4 Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Takeda Pharmaceutical Company Limited Recent Developments and Future Plans
2.4 Rottapharm (Meda AB)
2.4.1 Rottapharm (Meda AB) Details
2.4.2 Rottapharm (Meda AB) Major Business
2.4.3 Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
2.4.4 Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Rottapharm (Meda AB) Recent Developments and Future Plans
2.5 Pfizer, Inc.
2.5.1 Pfizer, Inc. Details
2.5.2 Pfizer, Inc. Major Business
2.5.3 Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
2.5.4 Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Pfizer, Inc. Recent Developments and Future Plans
2.6 Eisai Co. Ltd.
2.6.1 Eisai Co. Ltd. Details
2.6.2 Eisai Co. Ltd. Major Business
2.6.3 Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
2.6.4 Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Eisai Co. Ltd. Recent Developments and Future Plans
2.7 The Procter & Gamble Company
2.7.1 The Procter & Gamble Company Details
2.7.2 The Procter & Gamble Company Major Business
2.7.3 The Procter & Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
2.7.4 The Procter & Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 The Procter & Gamble Company Recent Developments and Future Plans
2.8 Mederi Therapeutics
2.8.1 Mederi Therapeutics Details
2.8.2 Mederi Therapeutics Major Business
2.8.3 Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
2.8.4 Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Mederi Therapeutics Recent Developments and Future Plans
2.9 Aros Pharma
2.9.1 Aros Pharma Details
2.9.2 Aros Pharma Major Business
2.9.3 Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
2.9.4 Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Aros Pharma Recent Developments and Future Plans
2.10 Torax Medical, Inc.
2.10.1 Torax Medical, Inc. Details
2.10.2 Torax Medical, Inc. Major Business
2.10.3 Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
2.10.4 Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Torax Medical, Inc. Recent Developments and Future Plans
2.11 BD
2.11.1 BD Details
2.11.2 BD Major Business
2.11.3 BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
2.11.4 BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 BD Recent Developments and Future Plans
2.12 EndoGastric Solutions
2.12.1 EndoGastric Solutions Details
2.12.2 EndoGastric Solutions Major Business
2.12.3 EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
2.12.4 EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 EndoGastric Solutions Recent Developments and Future Plans
2.13 Medigus Ltd.
2.13.1 Medigus Ltd. Details
2.13.2 Medigus Ltd. Major Business
2.13.3 Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
2.13.4 Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Medigus Ltd. Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Gastroesophageal Reflux Disease (GERD) Drugs and Devices by Company Revenue
3.2.2 Top 3 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players Market Share in 2022
3.2.3 Top 6 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players Market Share in 2022
3.3 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market: Overall Company Footprint Analysis
3.3.1 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market: Region Footprint
3.3.2 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market: Company Product Type Footprint
3.3.3 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value and Market Share by Type (2018-2023)
4.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Market Share by Application (2018-2023)
5.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Type (2018-2029)
6.2 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Application (2018-2029)
6.3 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country
6.3.1 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Country (2018-2029)
6.3.2 United States Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2018-2029)
6.3.3 Canada Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2018-2029)
6.3.4 Mexico Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Type (2018-2029)
7.2 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Application (2018-2029)
7.3 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country
7.3.1 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Country (2018-2029)
7.3.2 Germany Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2018-2029)
7.3.3 France Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2018-2029)
7.3.5 Russia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2018-2029)
7.3.6 Italy Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Region
8.3.1 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Region (2018-2029)
8.3.2 China Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2018-2029)
8.3.3 Japan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2018-2029)
8.3.4 South Korea Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2018-2029)
8.3.5 India Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2018-2029)
8.3.7 Australia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Type (2018-2029)
9.2 South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Application (2018-2029)
9.3 South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country
9.3.1 South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Country (2018-2029)
9.3.2 Brazil Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2018-2029)
9.3.3 Argentina Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country
10.3.1 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Country (2018-2029)
10.3.2 Turkey Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2018-2029)
10.3.4 UAE Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Drivers
11.2 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Restraints
11.3 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Industry Chain
12.2 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Upstream Analysis
12.3 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Midstream Analysis
12.4 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Gastroesophageal Reflux Disease (GERD) Drugs and Devices
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Gastroesophageal Reflux Disease (GERD) Drugs and Devices by Type
1.3.1 Overview: Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Market Share by Type in 2022
1.3.3 Medication
1.3.4 Minimally Invasive Surgery
1.3.5 Invasive Surgery
1.4 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market by Application
1.4.1 Overview: Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Heartburn
1.4.3 Acid reflux disorders
1.5 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size & Forecast
1.6 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast by Region
1.6.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Region, (2018-2029)
1.6.3 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Prospect (2018-2029)
1.6.4 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Prospect (2018-2029)
1.6.6 South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 AstraZeneca, Plc.
2.1.1 AstraZeneca, Plc. Details
2.1.2 AstraZeneca, Plc. Major Business
2.1.3 AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
2.1.4 AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 AstraZeneca, Plc. Recent Developments and Future Plans
2.2 Addex Therapeutics
2.2.1 Addex Therapeutics Details
2.2.2 Addex Therapeutics Major Business
2.2.3 Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
2.2.4 Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Addex Therapeutics Recent Developments and Future Plans
2.3 Takeda Pharmaceutical Company Limited
2.3.1 Takeda Pharmaceutical Company Limited Details
2.3.2 Takeda Pharmaceutical Company Limited Major Business
2.3.3 Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
2.3.4 Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Takeda Pharmaceutical Company Limited Recent Developments and Future Plans
2.4 Rottapharm (Meda AB)
2.4.1 Rottapharm (Meda AB) Details
2.4.2 Rottapharm (Meda AB) Major Business
2.4.3 Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
2.4.4 Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Rottapharm (Meda AB) Recent Developments and Future Plans
2.5 Pfizer, Inc.
2.5.1 Pfizer, Inc. Details
2.5.2 Pfizer, Inc. Major Business
2.5.3 Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
2.5.4 Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Pfizer, Inc. Recent Developments and Future Plans
2.6 Eisai Co. Ltd.
2.6.1 Eisai Co. Ltd. Details
2.6.2 Eisai Co. Ltd. Major Business
2.6.3 Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
2.6.4 Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Eisai Co. Ltd. Recent Developments and Future Plans
2.7 The Procter & Gamble Company
2.7.1 The Procter & Gamble Company Details
2.7.2 The Procter & Gamble Company Major Business
2.7.3 The Procter & Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
2.7.4 The Procter & Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 The Procter & Gamble Company Recent Developments and Future Plans
2.8 Mederi Therapeutics
2.8.1 Mederi Therapeutics Details
2.8.2 Mederi Therapeutics Major Business
2.8.3 Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
2.8.4 Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Mederi Therapeutics Recent Developments and Future Plans
2.9 Aros Pharma
2.9.1 Aros Pharma Details
2.9.2 Aros Pharma Major Business
2.9.3 Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
2.9.4 Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Aros Pharma Recent Developments and Future Plans
2.10 Torax Medical, Inc.
2.10.1 Torax Medical, Inc. Details
2.10.2 Torax Medical, Inc. Major Business
2.10.3 Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
2.10.4 Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Torax Medical, Inc. Recent Developments and Future Plans
2.11 BD
2.11.1 BD Details
2.11.2 BD Major Business
2.11.3 BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
2.11.4 BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 BD Recent Developments and Future Plans
2.12 EndoGastric Solutions
2.12.1 EndoGastric Solutions Details
2.12.2 EndoGastric Solutions Major Business
2.12.3 EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
2.12.4 EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 EndoGastric Solutions Recent Developments and Future Plans
2.13 Medigus Ltd.
2.13.1 Medigus Ltd. Details
2.13.2 Medigus Ltd. Major Business
2.13.3 Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
2.13.4 Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Medigus Ltd. Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Gastroesophageal Reflux Disease (GERD) Drugs and Devices by Company Revenue
3.2.2 Top 3 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players Market Share in 2022
3.2.3 Top 6 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players Market Share in 2022
3.3 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market: Overall Company Footprint Analysis
3.3.1 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market: Region Footprint
3.3.2 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market: Company Product Type Footprint
3.3.3 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value and Market Share by Type (2018-2023)
4.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Market Share by Application (2018-2023)
5.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Type (2018-2029)
6.2 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Application (2018-2029)
6.3 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country
6.3.1 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Country (2018-2029)
6.3.2 United States Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2018-2029)
6.3.3 Canada Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2018-2029)
6.3.4 Mexico Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Type (2018-2029)
7.2 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Application (2018-2029)
7.3 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country
7.3.1 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Country (2018-2029)
7.3.2 Germany Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2018-2029)
7.3.3 France Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2018-2029)
7.3.5 Russia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2018-2029)
7.3.6 Italy Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Region
8.3.1 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Region (2018-2029)
8.3.2 China Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2018-2029)
8.3.3 Japan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2018-2029)
8.3.4 South Korea Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2018-2029)
8.3.5 India Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2018-2029)
8.3.7 Australia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Type (2018-2029)
9.2 South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Application (2018-2029)
9.3 South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country
9.3.1 South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Country (2018-2029)
9.3.2 Brazil Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2018-2029)
9.3.3 Argentina Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country
10.3.1 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Country (2018-2029)
10.3.2 Turkey Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2018-2029)
10.3.4 UAE Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Drivers
11.2 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Restraints
11.3 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Industry Chain
12.2 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Upstream Analysis
12.3 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Midstream Analysis
12.4 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Region (2024-2029) & (USD Million)
Table 5. AstraZeneca, Plc. Company Information, Head Office, and Major Competitors
Table 6. AstraZeneca, Plc. Major Business
Table 7. AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
Table 8. AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. AstraZeneca, Plc. Recent Developments and Future Plans
Table 10. Addex Therapeutics Company Information, Head Office, and Major Competitors
Table 11. Addex Therapeutics Major Business
Table 12. Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
Table 13. Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Addex Therapeutics Recent Developments and Future Plans
Table 15. Takeda Pharmaceutical Company Limited Company Information, Head Office, and Major Competitors
Table 16. Takeda Pharmaceutical Company Limited Major Business
Table 17. Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
Table 18. Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Takeda Pharmaceutical Company Limited Recent Developments and Future Plans
Table 20. Rottapharm (Meda AB) Company Information, Head Office, and Major Competitors
Table 21. Rottapharm (Meda AB) Major Business
Table 22. Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
Table 23. Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Rottapharm (Meda AB) Recent Developments and Future Plans
Table 25. Pfizer, Inc. Company Information, Head Office, and Major Competitors
Table 26. Pfizer, Inc. Major Business
Table 27. Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
Table 28. Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Pfizer, Inc. Recent Developments and Future Plans
Table 30. Eisai Co. Ltd. Company Information, Head Office, and Major Competitors
Table 31. Eisai Co. Ltd. Major Business
Table 32. Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
Table 33. Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Eisai Co. Ltd. Recent Developments and Future Plans
Table 35. The Procter & Gamble Company Company Information, Head Office, and Major Competitors
Table 36. The Procter & Gamble Company Major Business
Table 37. The Procter & Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
Table 38. The Procter & Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. The Procter & Gamble Company Recent Developments and Future Plans
Table 40. Mederi Therapeutics Company Information, Head Office, and Major Competitors
Table 41. Mederi Therapeutics Major Business
Table 42. Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
Table 43. Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Mederi Therapeutics Recent Developments and Future Plans
Table 45. Aros Pharma Company Information, Head Office, and Major Competitors
Table 46. Aros Pharma Major Business
Table 47. Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
Table 48. Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Aros Pharma Recent Developments and Future Plans
Table 50. Torax Medical, Inc. Company Information, Head Office, and Major Competitors
Table 51. Torax Medical, Inc. Major Business
Table 52. Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
Table 53. Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Torax Medical, Inc. Recent Developments and Future Plans
Table 55. BD Company Information, Head Office, and Major Competitors
Table 56. BD Major Business
Table 57. BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
Table 58. BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. BD Recent Developments and Future Plans
Table 60. EndoGastric Solutions Company Information, Head Office, and Major Competitors
Table 61. EndoGastric Solutions Major Business
Table 62. EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
Table 63. EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. EndoGastric Solutions Recent Developments and Future Plans
Table 65. Medigus Ltd. Company Information, Head Office, and Major Competitors
Table 66. Medigus Ltd. Major Business
Table 67. Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
Table 68. Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Medigus Ltd. Recent Developments and Future Plans
Table 70. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million) by Players (2018-2023)
Table 71. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Share by Players (2018-2023)
Table 72. Breakdown of Gastroesophageal Reflux Disease (GERD) Drugs and Devices by Company Type (Tier 1, Tier 2, and Tier 3)
Table 73. Market Position of Players in Gastroesophageal Reflux Disease (GERD) Drugs and Devices, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 74. Head Office of Key Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players
Table 75. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market: Company Product Type Footprint
Table 76. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market: Company Product Application Footprint
Table 77. Gastroesophageal Reflux Disease (GERD) Drugs and Devices New Market Entrants and Barriers to Market Entry
Table 78. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Mergers, Acquisition, Agreements, and Collaborations
Table 79. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (USD Million) by Type (2018-2023)
Table 80. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Share by Type (2018-2023)
Table 81. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Forecast by Type (2024-2029)
Table 82. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Application (2018-2023)
Table 83. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Forecast by Application (2024-2029)
Table 84. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Type (2018-2023) & (USD Million)
Table 85. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Type (2024-2029) & (USD Million)
Table 86. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Application (2018-2023) & (USD Million)
Table 87. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Application (2024-2029) & (USD Million)
Table 88. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Country (2018-2023) & (USD Million)
Table 89. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Country (2024-2029) & (USD Million)
Table 90. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Application (2018-2023) & (USD Million)
Table 93. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Application (2024-2029) & (USD Million)
Table 94. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Type (2018-2023) & (USD Million)
Table 97. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Type (2024-2029) & (USD Million)
Table 98. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Application (2018-2023) & (USD Million)
Table 99. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Application (2024-2029) & (USD Million)
Table 100. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Region (2018-2023) & (USD Million)
Table 101. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Region (2024-2029) & (USD Million)
Table 102. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Type (2018-2023) & (USD Million)
Table 103. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Type (2024-2029) & (USD Million)
Table 104. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Application (2018-2023) & (USD Million)
Table 105. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Application (2024-2029) & (USD Million)
Table 106. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Country (2018-2023) & (USD Million)
Table 107. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Type (2018-2023) & (USD Million)
Table 109. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Type (2024-2029) & (USD Million)
Table 110. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Application (2018-2023) & (USD Million)
Table 111. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Application (2024-2029) & (USD Million)
Table 112. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Country (2018-2023) & (USD Million)
Table 113. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Country (2024-2029) & (USD Million)
Table 114. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Raw Material
Table 115. Key Suppliers of Gastroesophageal Reflux Disease (GERD) Drugs and Devices Raw Materials
Table 1. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Region (2024-2029) & (USD Million)
Table 5. AstraZeneca, Plc. Company Information, Head Office, and Major Competitors
Table 6. AstraZeneca, Plc. Major Business
Table 7. AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
Table 8. AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. AstraZeneca, Plc. Recent Developments and Future Plans
Table 10. Addex Therapeutics Company Information, Head Office, and Major Competitors
Table 11. Addex Therapeutics Major Business
Table 12. Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
Table 13. Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Addex Therapeutics Recent Developments and Future Plans
Table 15. Takeda Pharmaceutical Company Limited Company Information, Head Office, and Major Competitors
Table 16. Takeda Pharmaceutical Company Limited Major Business
Table 17. Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
Table 18. Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Takeda Pharmaceutical Company Limited Recent Developments and Future Plans
Table 20. Rottapharm (Meda AB) Company Information, Head Office, and Major Competitors
Table 21. Rottapharm (Meda AB) Major Business
Table 22. Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
Table 23. Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Rottapharm (Meda AB) Recent Developments and Future Plans
Table 25. Pfizer, Inc. Company Information, Head Office, and Major Competitors
Table 26. Pfizer, Inc. Major Business
Table 27. Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
Table 28. Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Pfizer, Inc. Recent Developments and Future Plans
Table 30. Eisai Co. Ltd. Company Information, Head Office, and Major Competitors
Table 31. Eisai Co. Ltd. Major Business
Table 32. Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
Table 33. Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Eisai Co. Ltd. Recent Developments and Future Plans
Table 35. The Procter & Gamble Company Company Information, Head Office, and Major Competitors
Table 36. The Procter & Gamble Company Major Business
Table 37. The Procter & Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
Table 38. The Procter & Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. The Procter & Gamble Company Recent Developments and Future Plans
Table 40. Mederi Therapeutics Company Information, Head Office, and Major Competitors
Table 41. Mederi Therapeutics Major Business
Table 42. Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
Table 43. Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Mederi Therapeutics Recent Developments and Future Plans
Table 45. Aros Pharma Company Information, Head Office, and Major Competitors
Table 46. Aros Pharma Major Business
Table 47. Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
Table 48. Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Aros Pharma Recent Developments and Future Plans
Table 50. Torax Medical, Inc. Company Information, Head Office, and Major Competitors
Table 51. Torax Medical, Inc. Major Business
Table 52. Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
Table 53. Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Torax Medical, Inc. Recent Developments and Future Plans
Table 55. BD Company Information, Head Office, and Major Competitors
Table 56. BD Major Business
Table 57. BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
Table 58. BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. BD Recent Developments and Future Plans
Table 60. EndoGastric Solutions Company Information, Head Office, and Major Competitors
Table 61. EndoGastric Solutions Major Business
Table 62. EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
Table 63. EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. EndoGastric Solutions Recent Developments and Future Plans
Table 65. Medigus Ltd. Company Information, Head Office, and Major Competitors
Table 66. Medigus Ltd. Major Business
Table 67. Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product and Solutions
Table 68. Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Medigus Ltd. Recent Developments and Future Plans
Table 70. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (USD Million) by Players (2018-2023)
Table 71. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Share by Players (2018-2023)
Table 72. Breakdown of Gastroesophageal Reflux Disease (GERD) Drugs and Devices by Company Type (Tier 1, Tier 2, and Tier 3)
Table 73. Market Position of Players in Gastroesophageal Reflux Disease (GERD) Drugs and Devices, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 74. Head Office of Key Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players
Table 75. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market: Company Product Type Footprint
Table 76. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market: Company Product Application Footprint
Table 77. Gastroesophageal Reflux Disease (GERD) Drugs and Devices New Market Entrants and Barriers to Market Entry
Table 78. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Mergers, Acquisition, Agreements, and Collaborations
Table 79. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (USD Million) by Type (2018-2023)
Table 80. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Share by Type (2018-2023)
Table 81. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Forecast by Type (2024-2029)
Table 82. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Application (2018-2023)
Table 83. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Forecast by Application (2024-2029)
Table 84. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Type (2018-2023) & (USD Million)
Table 85. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Type (2024-2029) & (USD Million)
Table 86. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Application (2018-2023) & (USD Million)
Table 87. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Application (2024-2029) & (USD Million)
Table 88. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Country (2018-2023) & (USD Million)
Table 89. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Country (2024-2029) & (USD Million)
Table 90. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Application (2018-2023) & (USD Million)
Table 93. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Application (2024-2029) & (USD Million)
Table 94. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Type (2018-2023) & (USD Million)
Table 97. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Type (2024-2029) & (USD Million)
Table 98. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Application (2018-2023) & (USD Million)
Table 99. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Application (2024-2029) & (USD Million)
Table 100. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Region (2018-2023) & (USD Million)
Table 101. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Region (2024-2029) & (USD Million)
Table 102. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Type (2018-2023) & (USD Million)
Table 103. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Type (2024-2029) & (USD Million)
Table 104. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Application (2018-2023) & (USD Million)
Table 105. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Application (2024-2029) & (USD Million)
Table 106. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Country (2018-2023) & (USD Million)
Table 107. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Type (2018-2023) & (USD Million)
Table 109. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Type (2024-2029) & (USD Million)
Table 110. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Application (2018-2023) & (USD Million)
Table 111. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Application (2024-2029) & (USD Million)
Table 112. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Country (2018-2023) & (USD Million)
Table 113. Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Country (2024-2029) & (USD Million)
Table 114. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Raw Material
Table 115. Key Suppliers of Gastroesophageal Reflux Disease (GERD) Drugs and Devices Raw Materials
LIST OF FIGURES
Figure 1. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Picture
Figure 2. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Market Share by Type in 2022
Figure 4. Medication
Figure 5. Minimally Invasive Surgery
Figure 6. Invasive Surgery
Figure 7. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Market Share by Application in 2022
Figure 9. Heartburn Picture
Figure 10. Acid reflux disorders Picture
Figure 11. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Market Share by Region in 2022
Figure 16. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Share by Players in 2022
Figure 22. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share in 2022
Figure 24. Global Top 6 Players Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share in 2022
Figure 25. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Share by Type (2018-2023)
Figure 26. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share Forecast by Type (2024-2029)
Figure 27. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Share by Application (2018-2023)
Figure 28. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share Forecast by Application (2024-2029)
Figure 29. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 39. France Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Market Share by Region (2018-2029)
Figure 46. China Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 49. India Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 63. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Drivers
Figure 64. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Restraints
Figure 65. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Gastroesophageal Reflux Disease (GERD) Drugs and Devices in 2022
Figure 68. Manufacturing Process Analysis of Gastroesophageal Reflux Disease (GERD) Drugs and Devices
Figure 69. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Picture
Figure 2. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Market Share by Type in 2022
Figure 4. Medication
Figure 5. Minimally Invasive Surgery
Figure 6. Invasive Surgery
Figure 7. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Market Share by Application in 2022
Figure 9. Heartburn Picture
Figure 10. Acid reflux disorders Picture
Figure 11. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Market Share by Region in 2022
Figure 16. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Share by Players in 2022
Figure 22. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share in 2022
Figure 24. Global Top 6 Players Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share in 2022
Figure 25. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Share by Type (2018-2023)
Figure 26. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share Forecast by Type (2024-2029)
Figure 27. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Share by Application (2018-2023)
Figure 28. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share Forecast by Application (2024-2029)
Figure 29. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 39. France Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Market Share by Region (2018-2029)
Figure 46. China Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 49. India Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Gastroesophageal Reflux Disease (GERD) Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 63. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Drivers
Figure 64. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Restraints
Figure 65. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Gastroesophageal Reflux Disease (GERD) Drugs and Devices in 2022
Figure 68. Manufacturing Process Analysis of Gastroesophageal Reflux Disease (GERD) Drugs and Devices
Figure 69. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
